Business Context and Reporting Period
This Form 8-K Current Report was filed by BIO-RAD LABORATORIES, INC. on March 23, 2022. The report addresses corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters.
Material Changes
- Director Departure: Alice N. Schwartz, a director and co-founder, informed the Company on March 23, 2022, of her decision not to stand for re-election at the 2022 Annual Meeting of Stockholders.
- Appointment: The Board of Directors appointed Mrs. Schwartz as Director Emeritus, effective April 26, 2022.
- Role Definition: As Director Emeritus, she may attend Board meetings and receive materials at the Secretary's discretion but holds no voting power and receives no compensation.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The document is limited to the announcement of the director's departure and honorary appointment.
Key Facts for Investors to Verify
- Confirmation of Alice N. Schwartz's departure from the voting Board of Directors.
- The effective date of her new title as Director Emeritus (April 26, 2022).
- Any potential impact on the Board's composition or governance structure at the upcoming 2022 Annual Meeting.